RUA Life Sciences Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of RUA?
Owner TypeNumber of SharesOwnership Percentage
Private Companies202,8960.327%
Public Companies2,522,6024.06%
Individual Insiders8,251,59513.3%
General Public22,183,16935.7%
Institutions28,900,01046.6%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Top 25 shareholders own 60.63% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
16.4%
Dowgate Capital Stockbrokers Limited , Asset Management Arm
10,156,764UK£1.3m0%0.75%
6.49%
Clive Titcomb
4,027,272UK£503.4k0%no data
6.48%
Rathbones Investment Management Limited
4,019,784UK£502.5k-0.73%no data
4.2%
Charles Stanley & Co. Ltd, Asset Management Arm
2,604,006UK£325.5k15.2%no data
4.12%
Mark Bradshaw
2,555,454UK£319.4k0%no data
3.54%
HBOS Investment Fund Managers Limited
2,195,843UK£274.5k-10.6%no data
2.16%
Lloyds Banking Group plc
1,339,284UK£167.4k19.1%no data
1.91%
WH Ireland Group plc
1,183,318UK£147.9k0%no data
1.75%
IG Group Holdings Plc, Asset Management Arm
1,087,082UK£135.9k-18.4%0.01%
1.59%
Barclays Bank PLC, Wealth and Investment Management Division
989,279UK£123.7k-16.1%no data
1.46%
SG Hambros Bank Limited, Asset Management Arm
909,090UK£113.6k0%0.04%
1.36%
William Brown
841,876UK£105.2k0%no data
1.25%
Amati Global Investors Ltd.
775,586UK£96.9k0%0.02%
1.25%
First Equity Ltd, Asset Management Arm
774,473UK£96.8k-22.1%0.12%
0.97%
UBS Asset Management AG
602,699UK£75.3k-2.43%no data
0.96%
Fidelity International Ltd
597,604UK£74.7k6.88%no data
0.86%
HSBC Global Asset Management (UK) Limited
534,601UK£66.8k6.4%no data
0.74%
Idealing.com, Asset Management Arm
462,281UK£57.8k0.43%0.04%
0.58%
Close Asset Management Limited
362,256UK£45.3k-38.9%no data
0.49%
James Wright
305,107UK£38.1k0%no data
0.46%
Shard Capital Partners LLP, Asset Management Arm
288,000UK£36.0k0%0.18%
0.45%
DEGIRO B.V., Asset Management Arm
276,324UK£34.5k46%0.02%
0.44%
Ian Ardill
272,727UK£34.1k0%no data
0.4%
Evelyn Partners Investment Management LLP
249,590UK£31.2k-27.2%no data
0.35%
James Sharp & Co., Asset Management Arm
214,250UK£26.8k0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/31 18:55
End of Day Share Price 2025/01/31 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

RUA Life Sciences plc is covered by 6 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Andrew Murray DarleyCavendish
Christopher DonnellanCavendish
Christopher DonnellanCavendish Historical (Cenkos Securities)